Novel Hit Compounds as Putative Antifungals: The Case of


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
25 Oct 2019
Historique:
received: 31 08 2019
revised: 19 10 2019
accepted: 23 10 2019
entrez: 17 11 2019
pubmed: 17 11 2019
medline: 24 4 2020
Statut: epublish

Résumé

The prevalence of invasive fungal infections has been dramatically increased as the size of the immunocompromised population worldwide has grown.

Identifiants

pubmed: 31731542
pii: molecules24213853
doi: 10.3390/molecules24213853
pmc: PMC6864791
pii:
doi:

Substances chimiques

Antifungal Agents 0
Azoles 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Education, Science and Technological Development of Republic of Serbia
ID : 173032

Références

Microbiol Mol Biol Rev. 2011 Jun;75(2):213-67
pubmed: 21646428
Emerg Infect Dis. 2009 Jul;15(7):1068-76
pubmed: 19624922
Chem Pharm Bull (Tokyo). 2014;62(1):16-24
pubmed: 24390489
Chem Biol Drug Des. 2006 Jan;67(1):83-4
pubmed: 16492153
J Chem Inf Model. 2005 Jan-Feb;45(1):160-9
pubmed: 15667141
Drugs Today (Barc). 2015 Dec;51(12):705-18
pubmed: 26798851
Drugs. 2011 Dec 24;71(18):2405-19
pubmed: 22141384
Curr Opin Microbiol. 2018 Oct;45:70-76
pubmed: 29547801
J Fungi (Basel). 2016 Jun 06;2(2):null
pubmed: 29376934
N Engl J Med. 2002 Aug 8;347(6):408-15
pubmed: 12167683
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Mayo Clin Proc. 2011 Aug;86(8):805-17
pubmed: 21803962
Biochem Pharmacol. 2017 Jun 1;133:86-96
pubmed: 27884742
Clin Infect Dis. 2010 Jun 15;50(12):1559-67
pubmed: 20450350
Mycoses. 2008 Sep;51 Suppl 4:2-15
pubmed: 18783559
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
J Mol Biol. 2010 Apr 9;397(4):1067-78
pubmed: 20149798
Curr Treat Options Infect Dis. 2014 Sep;6(3):309-325
pubmed: 25328449
J Chem Inf Model. 2005 Jan-Feb;45(1):177-82
pubmed: 15667143
Eur Respir Rev. 2011 Sep 1;20(121):156-74
pubmed: 21881144
Nat Rev Drug Discov. 2017 Sep;16(9):603-616
pubmed: 28496146
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3068-73
pubmed: 11248033
Int J Antimicrob Agents. 2006 Nov;28(5):450-3
pubmed: 17034993
Biochim Biophys Acta. 2007 Mar;1770(3):467-77
pubmed: 16963187
Cold Spring Harb Perspect Med. 2014 Nov 10;5(7):a019752
pubmed: 25384768
J Clin Microbiol. 2001 Apr;39(4):1360-7
pubmed: 11283057
Molecules. 2015 Dec 19;20(12):22799-832
pubmed: 26703541
Microorganisms. 2017 Aug 22;5(3):null
pubmed: 28829379
Drug Discov Today. 2010 Jun;15(11-12):444-50
pubmed: 20362693
Antimicrob Agents Chemother. 2011 May;55(5):2483-6
pubmed: 21300838
J Chem Inf Model. 2010 Apr 26;50(4):572-84
pubmed: 20235588
Mycoses. 1998;41 Suppl 1:32-8
pubmed: 9717384
Clin Microbiol Rev. 1999 Apr;12(2):310-50
pubmed: 10194462
ChemMedChem. 2018 Feb 6;13(3):251-258
pubmed: 29235267
Trends Microbiol. 2003 Jun;11(6):272-9
pubmed: 12823944
Eur J Med Res. 2011 Apr 28;16(4):153-7
pubmed: 21486729
J Chem Inf Model. 2010 May 24;50(5):822-39
pubmed: 20423098
Antimicrob Agents Chemother. 2010 Oct;54(10):4225-34
pubmed: 20660663
J Med Chem. 2004 Mar 25;47(7):1750-9
pubmed: 15027866
J Comput Chem. 2012 Jan 15;33(2):119-33
pubmed: 21997754
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
Med Mycol. 2016 May;54(4):400-8
pubmed: 26768370

Auteurs

Eftichia Kritsi (E)

Institute of Chemical Biology, National Hellenic Research Foundation, 48, Vas. Constantinou Avenue, 11635 Athens, Greece.

Minos-Timotheos Matsoukas (MT)

Department of Pharmacy, University of Patras, 26504 Patras, Greece.
Cloudpharm, Monumental Plaza, Building C, 44, Kifissias Avenue, Marousi, 15125 Athens, Greece.

Constantinos Potamitis (C)

Cloudpharm, Monumental Plaza, Building C, 44, Kifissias Avenue, Marousi, 15125 Athens, Greece.

Anastasia Detsi (A)

School of Chemical Engineering, National Technical University of Athens, 9, Iroon-Polytechneiou-Str, 15773 Athens, Greece.

Marija Ivanov (M)

Institute for Biological Research "Siniša Stanković"- National Institute of Republic of Serbia, University of Belgrade, 142, Bulevar Despota Stefana, 11000 Belgrade, Serbia.

Marina Sokovic (M)

Institute for Biological Research "Siniša Stanković"- National Institute of Republic of Serbia, University of Belgrade, 142, Bulevar Despota Stefana, 11000 Belgrade, Serbia.

Panagiotis Zoumpoulakis (P)

Institute of Chemical Biology, National Hellenic Research Foundation, 48, Vas. Constantinou Avenue, 11635 Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH